Healthcare DIVE June 23, 2021
Samantha Liss

Another healthcare venture promises to lower costs, this time through leveraging patient data on drug efficacy through a handful of large insurers.

Five Blue Cross Blue Shield Plans are joining forces to help launch a new venture with a lofty but familiar goal: to reduce the cost of prescription drugs.

The plans have invested in a new independent company, Evio, which will harness a trove of data to assess how well a drug works, and will ultimately try to align a drug’s cost with how well it performs.

The move is in step with the larger industry trends of moving toward a system that pays for the value of care instead of the volume of services provided. But some are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Insurance, Payer, Pharma, Pharma / Biotech, Pricing / Spending
Centene posts $1.2B profit in Q1
California lawmakers trying again for single-payer
Trauma-Informed Approach Enhances Substance Use Disorder Care, Appeals to Payers
Millions Were Booted From Medicaid. The Insurers That Run It Gained Revenue Anyway.
Centene Profits Eclipse $1 Billion Thanks To Big Obamacare Enrollment

Share This Article